Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human DDR2 Stable Cell Line

    [CAT#: S01YF-1123-KX214]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1101 Magic™ Human DDR2 in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    DDR2
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    MHCC-97H; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Auditory and Otology Research; Reproductive Research
    Related Diseases
    Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type and Warburg-Cinotti Syndrome. Among its related pathways are GPCR Pathway and ERK Signaling
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The DDR2 gene in humans encodes a protein called discoidin domain-containing receptor 2, or CD167b. Receptor tyrosine kinase 2 (RTK) is the receptor that possesses the discoidin domain. In order for cells to communicate with their surroundings, RTKs are essential. These chemicals play a role in the control of metabolism, differentiation, and cell proliferation. Collagen binds to the extracellular discoidin domain of DDR2 in this instance. The pleiotropic effects of signal transduction are mediated by the phosphorylation of cytosolic targets and their interaction with other molecules, which is caused via autophosphorylation. DDR2 has been linked to several illnesses, including as cancer and fibrosis. The customized DDR2 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Ashley

    The DDR2 cell line is easy to use, and the provided protocols are clear and straightforward. Its competitive pricing compared to other similar products on the market makes it an attractive option for researchers on a budget. Oct 21 2020

    chat Verified Customer

    chat Gary

    The DDR2 cell line is approximately lower than other brands of reagents and I got similar results. Sep 10 2021

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 The expression of DDR2 in cell lines and HCC tissues.

    Using qRT-PCR, DDR2 mRNA expression was measured in five hepatoma cell lines (MHCC-97H, HepG2, Huh-7, Hep3B, and SMMC-7721) and the immortalized normal human liver cell line L-02.

    Ref: Xie, Binhui, et al. "DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1." Journal of Experimental & Clinical Cancer Research 34.1 (2015): 1-13.

    Pubmed: 26362312

    DOI: 10.1186/s13046-015-0218-6

    Research Highlights

    DDR2 is positively linked and overexpressed in GC patients with adverse clinical characteristics. Through mTORC2 activation and AKT phosphorylation, DDR2 facilitates the EMT process, which in turn promotes tumor growth and invasion.
    Wang, Yu-Gang, et al. "DDR2 induces gastric cancer cell activities via activating mTORC2 signaling and is associated with clinicopathological characteristics of gastric cancer." Digestive diseases and sciences 61 (2016): 2272-2283.
    Pubmed: 27010547   DOI: 10.1007/s10620-016-4116-3

    Targeted small molecule inhibitors are not effective in treating most nonsmall cell lung cancers (NSCLCs), despite ten years of progress in precision medicine techniques. Previous research has revealed that Discoidin Domain Receptor 2 (DDR2) kinase mutations may be useful therapeutic targets in non-small cell lung cancers.
    Terai, Hideki, et al. "Characterization of DDR2 inhibitors for the treatment of DDR2 mutated nonsmall cell lung cancer." ACS chemical biology 10.12 (2015): 2687-2696.
    Pubmed: 26390252   DOI: 10.1021/acschembio.5b00655

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare